Is Kanna Legal? A State-by-State and International Breakdown
If you have been exploring the world of functional botanicals, you have probably come across kanna and wondered: is kanna legal where I live? It is a fair question, and the answer is more nuanced than a simple yes or no.
Kanna (Sceletium tortuosum) is a South African succulent with a growing reputation for mood elevation and anxiety relief, yet most people outside of botanical wellness circles have barely heard of it. That knowledge gap creates real confusion for health-conscious consumers who just want to make informed choices.
Here at Kamello, we believe that curiosity should never be punished by a wall of legal jargon. Our kava and kanna botanical beverage is crafted to bring ancient plant wisdom into your everyday routine, and we want you to feel completely confident before you take your first sip.
Here we will provide a thorough, country-by-country and state-by-state breakdown of where kanna stands today.
The Ancient Plant Wellness Culture Is Just Discovering
From South African Soil to Your Supplement Shelf
Kanna is the common name for Sceletium tortuosum, a succulent native to South Africa that indigenous San and Khoikhoi communities have used for centuries. Traditionally, it was prepared through fermentation, drying, or direct chewing, and each method produces a meaningfully different alkaloid profile.
That variation is directly relevant today because it informs how modern manufacturers standardize their extracts for consistent potency.
Modern extraction methods concentrate the plant's primary alkaloids, most notably mesembrine. Research published in the Journal of Ethnopharmacology shows that mesembrine functions not only as a serotonin reuptake inhibitor but also as a phosphodiesterase 4 (PDE4) inhibitor, a separate pathway that contributes additional anxiolytic effects.
That dual mechanism is what gives kanna its distinctive profile: mood support and social ease without the sedation or cognitive fog associated with alcohol or heavier pharmaceutical interventions.
Why No One Can Give You a Straight Answer (And What That Really Means)
Most substances are either explicitly scheduled as controlled substances or left entirely unregulated. Kanna occupies an unusual middle ground.
It is not listed in the United Nations Convention on Psychotropic Substances, and under WHO guidelines, adding any substance to that list requires a formal review by the Expert Committee on Drug Dependence. No such review has been initiated for kanna, meaning international scheduling remains a distant prospect rather than an imminent concern.
In the United States, the Drug Enforcement Administration has not added any Sceletium tortuosum alkaloids to the Controlled Substances Act. The FDA treats kanna as a dietary supplement ingredient rather than a drug, meaning products containing it can be sold legally as long as they do not make unapproved disease claims.
The landscape for botanical products can shift, however, and staying informed is worthwhile. At Kamello, transparency is foundational to how we operate. We encourage anyone with specific concerns to reach out through our contact page before purchasing so we can share the most current guidance available.
Is Kanna Legal in the U.S.? Here Is What Most States Look Like
Good News for the Majority: Federal Law Sets a Clear Baseline
Because kanna is unscheduled at the federal level, residents of most U.S. states can purchase kanna products, including ready-to-drink beverages like Kamello, without any legal concern. States with no known restrictions include California, New York, Texas, Florida, Colorado, Oregon, Washington, and the majority of others.
Kanna does not trigger the Federal Analogue Act, which sometimes catches other botanicals in legal limbo, because it is neither a controlled analog nor a structurally similar compound to any scheduled substance.
For wellness consumers in most states, the more relevant question tends to be product quality rather than legal standing. Is the kanna extract standardized to reflect the traditional preparation methods that shaped its alkaloid profile? Is the kava sourced from noble cultivars? Those are the questions Kamello was founded to answer affirmatively.
The Few States Worth Double-Checking Before You Order
While no U.S. state has formally scheduled Sceletium tortuosum, a small number have enacted broad analog or novel psychoactive substance laws that could theoretically apply to any botanical with mood-altering properties, depending on how enforcement is interpreted.
Louisiana deserves specific mention because of its historically aggressive approach to scheduling botanical substances, including kratom and certain synthetic cannabinoids. Kanna does not appear on Louisiana's controlled substance schedule, but residents there would do well to confirm current status locally before purchasing.
Arkansas, Indiana, and a handful of other states with expansive analog substance language may warrant a similar check. If you are unsure about your specific location, Kamello encourages you to contact our team directly for the most current guidance we can provide.
Beyond U.S. Borders: Where Kanna Stands Around the World
The Markets Where Kanna Flows Freely
Outside the United States, kanna is permitted in most developed markets. In the United Kingdom, it is not listed under the Misuse of Drugs Act 1971.
The Psychoactive Substances Act 2016 does broadly target substances with psychoactive effects, but it includes defined exemptions for food products and substances not known to cause significant social harm. Kanna currently falls outside the Act's enforcement focus, though the nuance of that exemption is worth understanding if you are based in the UK.
Canada does not schedule kanna under the Controlled Drugs and Substances Act, and it can be sold as a natural health product provided labeling complies with Health Canada requirements.
Australia and New Zealand permit kanna for personal use and sale under general supplement frameworks. The European Union has no bloc-wide restrictions, leaving oversight to individual member states, most of which impose no barriers at all.
Where Travelers Should Pause and Do Their Homework
South Africa presents a unique case because kanna is native there. The South African Health Products Regulatory Authority has classified certain Sceletium extracts as Schedule 0 substances, meaning they are available without prescription but remain subject to oversight. It is one of the few jurisdictions that has engaged directly with kanna's classification.
In parts of Eastern Europe and some Southeast Asian nations, novel psychoactive substance legislation is broad and inconsistently enforced, creating genuine ambiguity for travelers carrying botanical supplements.
If you plan to travel internationally with any kanna-containing product, checking destination customs and controlled substance rules in advance is always the safest approach. Kamello is currently focused on the U.S. market, where the legal picture is straightforward and our product is designed for full compliance.
Legal Does Not Mean Trustworthy: What the Regulatory Gap Really Means for You
The Wild West of Botanical Beverages and Why Brand Accountability Matters
Without mandatory third-party testing or standardized labeling requirements for kanna products, the market can easily become crowded with low-quality offerings making exaggerated claims. A legal product is not automatically a trustworthy one, and that distinction is enormous in a category this young.
A 2013 randomized controlled trial published in the Journal of Alternative and Complementary Medicine found statistically significant reductions in anxiety scores among participants using a standardized Sceletium tortuosum extract. That kind of clinical evidence sets a meaningful benchmark.
Consumers exploring functional botanical beverages should seek out brands whose products are rooted in that research, not brands simply capitalizing on wellness curiosity.
Kamello was founded on that standard. The blend in each can is formulated to deliver consistent, reliable relaxation and mood support, not to exploit a gray area.
How a Canned Botanical Beverage Gets to Your Door Legally
Ready-to-drink beverages containing botanical ingredients must comply with FDA rules governing both dietary supplements and food additives. For novel ingredients like kanna, the most common legal pathway is achieving GRAS status, which stands for Generally Recognized as Safe.
This designation requires either a long history of safe use or scientific consensus supported by qualified experts, and it is the mechanism responsible brands use to bring new botanicals to market properly.
Kava has a longer U.S. history in this space, though not without scrutiny. In 2002, the FDA issued a consumer advisory about rare cases of liver injury linked to kava supplements, which is why sourcing from noble kava cultivars rather than tudei varieties carries genuine weight.
Kanna is newer to that level of attention, making openness from brands in this space all the more valuable. If you are curious about how Kamello approaches sourcing and ingredient standards, our team is happy to walk you through the details. Reach out on our contact page anytime.
Kanna in the Real World: How the Market Is Already Moving
The Brands That Proved Kanna Could Reach Shelves
The botanical beverage category has grown steadily, and several brands have successfully brought kanna-containing products to U.S. consumers under existing supplement and food regulations.
Botanical Brewing Co. is frequently cited within the kava and kanna community as an early mover, offering kanna-containing products through both online and retail channels and establishing a proof of concept that this space can operate legally and sustainably.
That track record is telling. It shows that kanna's status does not present a barrier to market entry when products are anchored in sound science and honest consumer communication.
Why Kamello Is Doing Something the Functional Beverage Industry Has Not Seen Before
Kamello represents a genuine first in this space: a ready-to-drink canned beverage that combines both kava and kanna as its core identity. While other brands have offered one botanical or the other, no major RTD player has centered its entire brand around the synergistic pairing of both.
By launching into an environment where both ingredients are permitted under federal law, and by anchoring the product in clinical and traditional research, Kamello is staking out a category that does not yet have a name.
Calm, Legal, and Ready to Drink: Here Is Where Kamello Fits Into Your Routine
The short answer to "is kanna legal" is yes. Across the United States and most international markets, kanna is unscheduled and fully accessible to consumers. But legality is the floor, not the ceiling.
What separates a product worth trying from one worth ignoring is the commitment a brand makes to quality, transparency, and genuine consumer education. Kamello exists because kava and kanna deserve a modern home that takes them seriously.
Whether you are navigating daily stress, curious about a hangover-free social experience, or simply ready to add a new ritual to your routine, there is a can crafted for exactly that moment. Explore Kamello’s ready-to-drink options today and discover your new ritual for calm.
Frequently Asked Questions
Is kanna the same as kratom from a legal standpoint?
Kanna and kratom are often grouped together in casual conversation, but from a regulatory and pharmacological perspective, they are fundamentally different substances.
Kanna, derived from Sceletium tortuosum, is not currently listed in the federal Controlled Substances Act schedules, which are publicly maintained by the U.S. Drug Enforcement Administration and can be reviewed in the official Controlled Substances Act schedules.
Kratom, by contrast, has been the subject of ongoing regulatory attention, including safety warnings from the U.S. Food and Drug Administration outlining concerns about dependence, contamination, and adverse health effects, as described in the FDA’s public health advisories on kratom.
These differences in regulatory attention reflect differences in both safety signals and historical use patterns. While kanna has been studied for its potential anxiolytic and mood-modulating effects in controlled settings, kratom has been associated with a higher volume of adverse event reports and has prompted more aggressive state-level restrictions. This distinction helps explain why kratom is banned or restricted in multiple U.S. states, while kanna remains unscheduled at the federal level.
Even so, “unscheduled” does not mean universally unrestricted. Kanna’s legal status is better understood as not currently listed under federal controlled substance laws, while still existing within a broader and evolving regulatory landscape. State laws, local enforcement practices, and future federal reviews could all influence how kanna is treated over time, making it important to stay informed rather than assuming permanence.
Does kanna show up on a standard drug test?
Standard workplace drug testing in the United States typically follows federally regulated panels that screen for a specific set of substances. These commonly include marijuana (THC), cocaine, amphetamines, opioids, and phencyclidine (PCP), as outlined in federal guidance from the Substance Abuse and Mental Health Services Administration in its drug testing resources.
Kanna’s primary alkaloids, such as mesembrine, are not included in these standard testing panels. Because of this, kanna is not expected to appear in routine employment drug screens that follow federal testing protocols.
However, drug testing practices are not identical across all employers or industries. Some organizations use expanded panels or specialized toxicology testing that may include a wider range of substances depending on policy or regulatory requirements.
There is currently limited human toxicology research specifically evaluating how kanna metabolites behave in drug testing contexts. For that reason, it is more scientifically accurate to say that kanna is not part of standard federally regulated drug panels rather than claiming it cannot be detected under any circumstances.
Individuals subject to strict testing environments, such as healthcare, transportation, or federal employment, should confirm specific testing policies in advance.
Does kanna have any known side effects?
Human research on kanna is still emerging, but available evidence suggests it is generally well tolerated when used in moderate, standardized amounts.
Some individuals report mild and transient effects such as headache, nausea, or gastrointestinal discomfort, particularly when taken on an empty stomach or at higher doses. These findings are consistent with early clinical observations and safety summaries, though the total volume of human data remains limited.
From a mechanistic standpoint, kanna’s alkaloids have been shown to influence serotonin transport and intracellular signaling pathways. Pharmacological research, including a study published in the Journal of Ethnopharmacology, describes how compounds like mesembrine act on the serotonin transporter and phosphodiesterase-4 system, contributing to its observed effects on mood and stress response.
Because of this serotonergic activity, there is a theoretical risk of interaction with medications that also affect serotonin levels.
Authoritative safety reviews emphasize that kanna has not been studied as extensively as many pharmaceutical compounds, and long-term safety data are still limited. For example, the U.S. Department of Defense’s supplement safety resource notes that while early research is promising, more evidence is needed to fully understand risks and benefits.
Individuals who are pregnant, taking prescription medications, or managing mental health conditions should approach use cautiously and consider professional guidance.
Is kanna FDA-approved?
Kanna is not FDA-approved as a drug, and understanding this distinction is important when evaluating botanical products.
In the United States, FDA approval applies specifically to pharmaceutical drugs that have undergone extensive clinical testing to demonstrate safety and efficacy for treating specific medical conditions. Kanna, by contrast, is typically marketed as a dietary supplement ingredient or included in functional food and beverage formulations, which are regulated under a different framework.
Under dietary supplement regulations, products do not require premarket approval from the FDA. Instead, manufacturers are responsible for ensuring safety and compliance with labeling rules. These rules limit the types of claims that can be made. According to FDA guidance on structure and function claims, companies may describe how a product supports normal physiological function but cannot claim that it diagnoses, treats, cures, or prevents disease.
This distinction explains why a substance can be legally sold without being FDA-approved. It also reinforces the importance of evaluating product quality, ingredient transparency, and labeling accuracy. In the absence of a formal drug approval process, consumers rely more heavily on manufacturers to adhere to regulatory standards and scientific integrity.
What is the difference between legal, FDA-approved, and GRAS?
The terms “legal,” “FDA-approved,” and “GRAS” are often used interchangeably, but they refer to very different regulatory concepts.
“Legal” simply means that a substance is not prohibited under current law. For kanna, this means it is not listed in the federal controlled substance schedules and can be sold within existing supplement or food frameworks.
“FDA-approved” refers specifically to drugs that have been evaluated through a formal regulatory process involving clinical trials and FDA review. This designation confirms that a product has been proven safe and effective for a defined medical use. Most botanical ingredients, including kanna, are not evaluated through this pathway because they are not marketed as pharmaceutical treatments.
“GRAS,” or Generally Recognized as Safe, is a designation used for certain food ingredients. According to FDA guidance on GRAS substances, this status is based on either a long history of safe use in food or a scientific consensus among qualified experts.
GRAS does not mean a substance is FDA-approved as a drug, and it does not apply universally to all dietary supplements. Understanding these distinctions helps clarify how a product can be legal while still operating outside the pharmaceutical approval framework.
Can kanna interact with medications?
Kanna has pharmacological properties that suggest a potential for interaction with certain medications, even though direct clinical interaction studies in humans are limited.
Its primary alkaloids, including mesembrine and mesembrenone, have been shown to affect serotonin transport and intracellular signaling pathways. These mechanisms are described in pharmacological literature such as this peer-reviewed study on Sceletium tortuosum, which highlights its activity at the serotonin transporter and phosphodiesterase-4 enzyme.
Because of this serotonergic activity, there is a theoretical risk when kanna is combined with medications that also influence serotonin levels. These include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), and certain stimulant medications. Combining multiple serotonergic agents can increase the risk of excessive serotonin activity, which in some cases may lead to serotonin toxicity.
In addition to serotonergic effects, botanical compounds can interact with metabolic pathways that influence how drugs are processed in the body. While kanna-specific enzyme interaction data are still emerging, general pharmacology principles support a cautious approach when combining any bioactive botanical with prescription medications.
Individuals taking medications or managing chronic health conditions should consider consulting a qualified healthcare professional before incorporating kanna into their routine.